Half-dose photodynamic therapy offers robust anatomic improvement for patients with acute central serous chorioretinopathy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback